Novel Therapeutics in Haemato-Oncology – Hope or Hype?
Abstract
editorial DOI 10.1007/s12254-009-0104-z Printed in Austria # Springer-Verlag 2009 genicity of cancer cells might produce collateral damage The past decade has seen a quantum leap in our level of in normal cells which share these properties. Despite this, understanding of the malignant process and anticancer there has been an extreme hype regarding the low toxicity drug development. In cancer medicine diagnostic innova- of targeted drugs. Indeed, some have turned out to be tions, novel drugs...